Wird geladen...
The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A
BACKGROUND: Acquired haemophilia A (AHA) is a rare bleeding disorder caused by the development of specific autoantibodies against naturally occurring factor VIII (FVIII). Although about half of cases are idiopathic, AHA may be associated with several non-neoplastic conditions, autoimmune disorders,...
Gespeichert in:
| Veröffentlicht in: | Blood Transfus |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Edizioni SIMTI - SIMTI Servizi Srl
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918557/ https://ncbi.nlm.nih.gov/pubmed/26509821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2015.0090-15 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|